Copyright Reports & Markets. All rights reserved.

Global Alopecia Treatment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Alopecia Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Alopecia Treatment Market Size Growth Rate by Product
      • 1.4.2 Topical Drugs
      • 1.4.3 Oral Drugs
      • 1.4.4 Injectable
      • 1.4.5 Hair Transplant Services
      • 1.4.6 Other
    • 1.5 Market by End User
      • 1.5.1 Global Alopecia Treatment Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Dermatology And Trichology Clinics
      • 1.5.4 Home Care Settings
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Alopecia Treatment Market Size
      • 2.1.1 Global Alopecia Treatment Revenue 2014-2025
      • 2.1.2 Global Alopecia Treatment Sales 2014-2025
    • 2.2 Alopecia Treatment Growth Rate by Regions
      • 2.2.1 Global Alopecia Treatment Sales by Regions
      • 2.2.2 Global Alopecia Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Alopecia Treatment Sales by Manufacturers
      • 3.1.1 Alopecia Treatment Sales by Manufacturers
      • 3.1.2 Alopecia Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Alopecia Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Alopecia Treatment Revenue by Manufacturers
      • 3.2.1 Alopecia Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Alopecia Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Alopecia Treatment Price by Manufacturers
    • 3.4 Alopecia Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Alopecia Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Alopecia Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Alopecia Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Alopecia Treatment Sales by Product
    • 4.2 Global Alopecia Treatment Revenue by Product
    • 4.3 Alopecia Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Alopecia Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Alopecia Treatment by Countries
      • 6.1.1 North America Alopecia Treatment Sales by Countries
      • 6.1.2 North America Alopecia Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Alopecia Treatment by Product
    • 6.3 North America Alopecia Treatment by End User

    7 Europe

    • 7.1 Europe Alopecia Treatment by Countries
      • 7.1.1 Europe Alopecia Treatment Sales by Countries
      • 7.1.2 Europe Alopecia Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Alopecia Treatment by Product
    • 7.3 Europe Alopecia Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Alopecia Treatment by Countries
      • 8.1.1 Asia Pacific Alopecia Treatment Sales by Countries
      • 8.1.2 Asia Pacific Alopecia Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Alopecia Treatment by Product
    • 8.3 Asia Pacific Alopecia Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Alopecia Treatment by Countries
      • 9.1.1 Central & South America Alopecia Treatment Sales by Countries
      • 9.1.2 Central & South America Alopecia Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Alopecia Treatment by Product
    • 9.3 Central & South America Alopecia Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Alopecia Treatment by Countries
      • 10.1.1 Middle East and Africa Alopecia Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Alopecia Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Alopecia Treatment by Product
    • 10.3 Middle East and Africa Alopecia Treatment by End User

    11 Company Profiles

    • 11.1 Teva Pharmaceutical Industries
      • 11.1.1 Teva Pharmaceutical Industries Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Teva Pharmaceutical Industries Alopecia Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Teva Pharmaceutical Industries Alopecia Treatment Products Offered
      • 11.1.5 Teva Pharmaceutical Industries Recent Development
    • 11.2 Merck
      • 11.2.1 Merck Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Merck Alopecia Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Merck Alopecia Treatment Products Offered
      • 11.2.5 Merck Recent Development
    • 11.3 Johnson＆Johnson
      • 11.3.1 Johnson＆Johnson Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Johnson＆Johnson Alopecia Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Johnson＆Johnson Alopecia Treatment Products Offered
      • 11.3.5 Johnson＆Johnson Recent Development
    • 11.4 Reddy's Laboratories
      • 11.4.1 Reddy's Laboratories Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Reddy's Laboratories Alopecia Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Reddy's Laboratories Alopecia Treatment Products Offered
      • 11.4.5 Reddy's Laboratories Recent Development
    • 11.5 Cipla
      • 11.5.1 Cipla Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Cipla Alopecia Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Cipla Alopecia Treatment Products Offered
      • 11.5.5 Cipla Recent Development
    • 11.6 Cellmid
      • 11.6.1 Cellmid Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Cellmid Alopecia Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Cellmid Alopecia Treatment Products Offered
      • 11.6.5 Cellmid Recent Development
    • 11.7 Himalaya Drug
      • 11.7.1 Himalaya Drug Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Himalaya Drug Alopecia Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Himalaya Drug Alopecia Treatment Products Offered
      • 11.7.5 Himalaya Drug Recent Development
    • 11.8 Taisho Pharmaceutical Holdings
      • 11.8.1 Taisho Pharmaceutical Holdings Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Taisho Pharmaceutical Holdings Alopecia Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Taisho Pharmaceutical Holdings Alopecia Treatment Products Offered
      • 11.8.5 Taisho Pharmaceutical Holdings Recent Development

    12 Future Forecast

    • 12.1 Alopecia Treatment Market Forecast by Regions
      • 12.1.1 Global Alopecia Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Alopecia Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Alopecia Treatment Market Forecast by Product
      • 12.2.1 Global Alopecia Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Alopecia Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Alopecia Treatment Market Forecast by End User
    • 12.4 North America Alopecia Treatment Forecast
    • 12.5 Europe Alopecia Treatment Forecast
    • 12.6 Asia Pacific Alopecia Treatment Forecast
    • 12.7 Central & South America Alopecia Treatment Forecast
    • 12.8 Middle East and Africa Alopecia Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Alopecia Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Alopecia Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Alopecia Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Alopecia Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Alopecia Treatment in these regions.
      This research report categorizes the global Alopecia Treatment market by top players/brands, region, type and end user. This report also studies the global Alopecia Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Teva Pharmaceutical Industries
      Merck
      Johnson＆Johnson
      Reddy's Laboratories
      Cipla
      Cellmid
      Himalaya Drug
      Taisho Pharmaceutical Holdings

      Market size by Product
      Topical Drugs
      Oral Drugs
      Injectable
      Hair Transplant Services
      Other
      Market size by End User
      Hospitals
      Dermatology And Trichology Clinics
      Home Care Settings
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Alopecia Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Alopecia Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Alopecia Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Alopecia Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Alopecia Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alopecia Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now